The increasing reliance on blood tests for prostate cancer detection is placing a significant strain on doctors, leading to diagnostic backlogs. Now, researchers at the Norwegian University of Science and Technology (NTNU) have developed an artificial intelligence (AI) tool designed to alleviate this burden and improve the speed and accuracy of diagnoses.
Prostate cancer is the most commonly diagnosed cancer among men in Western countries, with examinations detecting the disease in approximately 10% of men aged 50, rising to 50% by age 60 and around 70% in men over 80. While often a slow-growing cancer, the surge in PSA testing – a blood test used to screen for prostate cancer – has led to a substantial increase in the number of modern cases identified annually, now reaching approximately 5,000 in some regions. This increased volume necessitates more efficient diagnostic pathways.
The new AI-powered tool, called PROVIZ, focuses on analyzing magnetic resonance imaging (MRI) scans of the prostate. “AI tools can take over the detection of simple and clear-cut cases, allowing doctors to spend their time on more complex ones,” explains Tone Frost Bathen, a professor at NTNU and the project manager for PROVIZ. The tool aims to help radiologists quickly and accurately determine whether a biopsy is needed and, crucially, pinpoint the precise location within the prostate for sampling.
Improving Diagnostic Accuracy and Efficiency
Currently, interpreting prostate MRI scans is a manual process requiring the expertise of experienced radiologists. As the number of scans increases, the demand for their time grows, creating a necessitate for innovative solutions. PROVIZ is designed to assist in this process, offering a second opinion and potentially accelerating the diagnostic timeline. Initial tests conducted at St. Olavs Hospital have shown promising results, suggesting the tool’s potential to enhance diagnostic accuracy.
However, the successful integration of AI into healthcare isn’t solely about technological advancement. A recent study conducted by NTNU researchers, published in Qualitative Health Research (DOI:10.1177/10497323251387545), highlights the critical role of patient trust. The study found that patients are more likely to accept AI-driven diagnoses when accompanied by confirmation from an experienced physician.
The Importance of the Doctor-Patient Relationship
“Trust in doctors and health professionals is key for artificial intelligence to gain a place in the diagnosis of prostate cancer. Technology alone is not enough. Human contact and professional assessment remain indispensable,” says Simon A. Berger, a PhD research fellow at NTNU. The research team interviewed 18 men diagnosed with prostate cancer using PROVIZ and identified three key dimensions of trust:
- Foundational trust in the healthcare system: Positive prior experiences with healthcare providers build a base level of confidence.
- Inter-personal trust in health professionals: Patients rely on their doctors’ assessments and explanations, which are crucial for accepting AI-assisted diagnoses.
- Possible trust in AI: While recognizing the potential benefits of AI, patients still desire a human assessment to ensure accountability and comprehensive clinical judgment.
Berger emphasizes that the doctor-patient relationship remains paramount. “Patients accept the use of AI within a framework they already trust,” he explains. For AI to be effectively implemented, healthcare professionals must be able to clearly communicate how the technology arrives at its conclusions and verify its accuracy.
Looking Ahead
The PROVIZ project is currently in the research phase, with efforts underway to secure a patent and make the tool commercially available. While AI offers a promising avenue for streamlining prostate cancer diagnostics, the research underscores the importance of maintaining a human-centered approach. The successful adoption of these technologies will depend on fostering trust between patients, physicians, and the AI systems themselves.
The development of AI tools like PROVIZ represents a significant step towards personalized medicine in prostate cancer, aiming to improve patient quality of life and reduce mortality. As AI continues to evolve, its role in healthcare will undoubtedly expand, but the human element will remain essential for ensuring accurate diagnoses and building patient confidence.
Disclaimer: This article provides informational content and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
What are your thoughts on the role of AI in healthcare? Share your comments below.
